Solara Active Pharma Sciences Ltd (SOLA)

BSE
Currency in INR
543.00
+6.95(+1.30%)
Closed
SOLA Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
539.10549.00
52 wk Range
321.93885.95
Key Statistics
Edit
Bid/Ask
543.00 / 547.00
Prev. Close
543
Open
547.95
Day's Range
539.1-549
52 wk Range
321.93-885.95
Volume
5.84K
Average Volume (3m)
10.82K
1-Year Change
50.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SOLA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry
Show more

Solara Active Pharma Sciences Ltd Company Profile

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antifungal, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

Employees
2156
Market
India

Compare SOLA to Peers and Sector

Metrics to compare
SOLA
Peers
Sector
Relationship
P/E Ratio
−10.2x28.3x−0.6x
PEG Ratio
0.720.180.00
Price/Book
2.4x2.8x2.6x
Price / LTM Sales
2.0x2.4x3.1x
Upside (Analyst Target)
4.2%13.1%48.8%
Fair Value Upside
Unlock−11.7%7.5%Unlock

Earnings

Latest Release
Jan 27, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / 4.362B
EPS Revisions
Last 90 days

FAQ

What Is the Solara Active Pharma (SOLA) Stock Price Today?

The Solara Active Pharma stock price today is 543.00.

What Stock Exchange Does Solara Active Pharma Trade On?

Solara Active Pharma is listed and trades on the BSE stock exchange.

What Is the Stock Symbol for Solara Active Pharma?

The stock symbol for Solara Active Pharma is "SOLA."

What Is the Solara Active Pharma Market Cap?

As of today, Solara Active Pharma market cap is 26.10B.

What is Solara Active Pharma Earnings Per Share?

The Solara Active Pharma EPS is -97.95.

From a Technical Analysis Perspective, Is SOLA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.